Personalized medicine of non-gene-specific chemotherapies for non-small cell lung cancer
Non-small cell lung cancer is recognized as the deadliest cancer across the globe. In some areas, it is more common in women than even breast and cervical cancer. Its rise, vaulted by smoking habits and increasing air pollution, has garnered much attention and resource in the medical field. The firs...
Saved in:
Main Authors: | Wenxiao Jiang, Guiqing Cai, Peter Hu, Yue Wang |
---|---|
Format: | article |
Language: | EN |
Published: |
Elsevier
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/8201e3885f3f42649a3d9af8a4a8c852 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical applications of pharmacogenomics
by: Quiñones,Luis, et al.
Published: (2017) -
Impact of Updating Pharmacogenetic Results: Lessons Learned from the PREDICT Program
by: Michelle Liu, et al.
Published: (2021) -
The pharmacogenomics journal
Published: (2001) -
Pharmacogenomics and Personalized Medicine in Type 2 Diabetes Mellitus: Potential Implications for Clinical Practice
by: Venkatachalapathy P, et al.
Published: (2021) -
Immunotherapy in patients with non-small cell lung cancer with ECOG PS 2
by: Damian Mojsak, et al.
Published: (2021)